Pay in 4 interest-free payments of $6.91 Learn more
Ships within 48 hours · Estimated delivery Sep 5 - Sep 10
Siepel, A
In addition, we included semaglutide prescriptions where the brand was unknown, if the patient had prior evidence of obesity and no prior evidence of type 2 diabetes (T2D)
Table 4
June 17 Product: AstraZenecas Imfinzi Indication: Endometrial cancer Monday, the FDA granted approval for AstraZenecas Imfinzi, in combination with chemotherapy, to treat primary advanced or recurrent endometrial cancer that is mismatch repair (MMR) deficient
US$ 24.81
US$ 26.47
US$ 23.73
US$ 25.43
US$ 24.42
US$ 26.04
US$ 29.58
US$ 24.89
US$ 23.24
US$ 25.49
US$ 22.91
US$ 27.25
US$ 29.40
US$ 21.15
US$ 28.03
US$ 25.37
